Meet In CommonNews

Local

Novo's investigational CagriSema, a GLP-1 and amylin analog, demonstrated ~21% average weight loss with lower doses in the REDEFINE 9 trial, presented at ObesityWeek® 2026 and published in The Lancet Diabetes & Endocrinology

Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.

Source: Moulton Advertiser

REDEFINE 9 trial showed CagriSema 1.7 mg / 1.7 mg and 1.0 mg / 1.0 mg produced estimated average weight loss of 20.7% and 21.0%, respectively, at 68 weeks, compared with 2.0% with placebo, in adults with overweight or obesity,…

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at Moulton Advertiser

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

Yutori

Yutori 3375 El Camino Real Palo Alto, CA, 94306 US

Cafe Riace

Cafe Riace 200 Sheridan Avenue Palo Alto, CA, US

City guide for Palo Alto, CA

Community Poll

Creators should be compensated when their work is used commercially to train AI systems.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer